5'-mG-mC*-mC*-mU*-mC*-dA-dG-dT-dC*-dT-dG-dC*-dT-dT-dC*-mG-mC*-mA-mC*-mC*-3' 2'-O-(2-methoxyethyl) nucleoside (m) and 2'-deoxynucleoside (d) with methyl group at position 5 of C and U (*)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C10 LIPID MODIFYING AGENTS
C10A LIPID MODIFYING AGENTS, PLAIN
C10AX Other lipid modifying agents
C10AX11 Mipomersen
D08946 Mipomersen sodium (USAN)
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Organismal systems
Digestive system
APOB
D08946 Mipomersen sodium (USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D08946
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08946
